Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma

Journal of Genetic Engineering and Biotechnology · Volume 21, Issue 1 (2023) · pp. 113

DOI: 10.1186/s43141-023-00577-8

Abstract

No abstract